Gynecologic Oncology

Gynecologic Oncology Clinic
Physicians' Office Building
Suite 600, 725 Irving Ave
Syracuse, NY 13210
Map & direction
Phone: 315 464-5162
Fax: 315 464-4613

The division of Gynecologic Oncology provides comprehensive care for women with gynecologic malignancies. Women with known or suspected cancers of the female genital tract (vulva, vagina, cervix, uterus, fallopian tube, ovary), are offered a full range of diagnostic and therapeutic options, including radical surgery, radiation therapy, and chemotherapy, as well as newer options, such as laparoscopic surgery and home chemotherapy when appropriate.

Through our participation in the National Cancer Institute External Icon's External link Gynecologic Oncology Group, patients have access to the latest developments in therapy, including the opportunity to participate in both regional and national clinical trials.

Our comprehensive approach includes exceptional nursing support for both inpatients and outpatients as well as access to a full range of supportive services including:

  • Nutritional and Psychological Counseling
  • Ovarian cancer risk assessment for patients with possible Familial Ovarian Cancer Syndrome includes full discussion of screening tests and options, with availability of:
    • vaginal ultrasound, CA-125 testing
    • genetic testing for BRCA-1 and BRCA-2
    • Laparoscopic prophylactic oophorectomy is offered for those at extremely high risk

Mary J Cunningham, MD

Mary J Cunningham, MD
Appointed 03/03/97
Women's Health Network
600 Physicians' Office Building
725 Irving Ave
Syracuse, NY 13210
315 464-5162

Current Appointments

Hospital Campus

  • Downtown

Clinical Section Affiliations

  • Obstetrics and Gynecology: Gynecologic Oncology
  • Upstate Cancer Center: Gynecologic Oncology
  • Women's Health Network: Obstetric, Gynecology & Urogynecology

Research Programs and Affiliations

  • Obstetrics and Gynecology

Clinic/Unit

Education & Fellowships

  • Fellowship: University of Pennsylvania Health System, 1991
  • Residency: University of Pennsylvania Health System, 1988
  • MD: Northwestern University Medical School, 1984

Clinical Trials

  • GOG 0212: A Randomized Phase III Trial Of Maintenance Chemotherapy Comparing 12 Monthly Cycles Of Single Agent Paclitaxel Or Xyotax (CT-2103) (Ind# 70177) Versus No Treatment Until Documented Relapse In Women With Advanced Ovarian Or Primary Peritoneal Cancer Who Achieve A Complete Clinical Response To Primary Platinum/Taxane Chemotherapy.
    Read more
  • GOG 0213: A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865, IND #113912) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865, IND #113912)
    Read more
  • GOG 0258:A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma
    Read more

Specialties & Certification

  • Gynecologic Oncology

Diseases & Conditions Treated

  • Cervical Cancer
  • Endometrial Cancer/Uterine Cancer
  • Fallopian Tube Cancer
  • Ovarian Cancer
  • Vaginal Cancer
  • Vulvar Cancer

Treats

  • Adults

Treatments/Services

  • Gynecologic Laparoscopic Surgery

Current Hospital Privileges

  • Upstate University Hospital
  • Crouse Hospital
Clinical Profile Shortcut: http://www.upstate.edu/findadoc/cunningm
Faculty Profile Shortcut: http://www.upstate.edu/faculty/cunningm